Indian Journal of Gastroenterology

, Volume 37, Issue 3, pp 243–247 | Cite as

Prevalence of celiac disease among pediatric patients with cryptogenic cirrhosis and effect of gluten-free-diet

  • Ashish Joshi
  • Sushil Falodia
  • Naveen KumarEmail author
  • Pawan Gupta
  • P. C. Khatri
Original Article



Liver involvement in celiac disease (CD) is classified into autoimmune and cryptogenic. The association between CD and autoimmune liver diseases like autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis is well-established; however, the data on patients with cryptogenic cirrhosis, particularly from India, are scanty. So we did this study to find the prevalence of CD in patients with cryptogenic cirrhosis.


This was a prospective observational study, involving children of less than 18 years old attending Pediatric and Gastroenterology clinic with a diagnosis of cryptogenic cirrhosis. The patients were evaluated for CD and divided into two groups: chronic liver disease (CLD) with CD, and CLD without CD. Both the groups were followed up for 6 months. CLD with CD group was treated with gluten-free-diet (GFD) and CLD without CD group was followed up without any specific intervention except standard care of CLD.


Out of 84 patients, 11 (13.1%) were diagnosed as CLD with CD. There was an improvement in hemoglobin levels, liver function tests, and Child-Pugh score after initiation of GFD in CLD with CD group.


The prevalence of CD in cryptogenic cirrhosis was 13.1%. Screening for CD is recommended for cryptogenic cirrhosis. Hepatic functions improve with a GFD in CD patients with cirrhosis.


Celiac disease Child-Pugh score Cryptogenic cirrhosis Gluten-free-diet 


Compliance with ethical standards

Conflicts of interest

AJ, SF, NK, PK, PG, and PCK declare that they have no conflict of interest.

Ethics statement

The study was performed in a manner to conform with the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on

The study protocol was approved by the institutional review board and ethics committee.


  1. 1.
    Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med. 2002;346:180–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.CrossRefPubMedGoogle Scholar
  3. 3.
    Sood A, Midha V, Sood N, et al. Prevalence of celiac disease among school going children in Punjab, North India. J Gastroenterol Hepatol. 2006;21:1622–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Hu WT, Murray JA, Greenway MC, et al. Cognitive impairment and celiac disease. Arch Neurol. 2006;63:1440–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128 Suppl 1 :S87–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Frustaci A, Cuoco L, Chimenti C, et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002;105:2611–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.CrossRefPubMedGoogle Scholar
  8. 8.
    Maggiore G, Caprai S. Liver involvement in celiac disease. Indian J Pediatr. 2006;73:809–11.CrossRefPubMedGoogle Scholar
  9. 9.
    De Franceschi L, Volta U, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci. 1998;43:2190–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Mounajjed T, Oxentenko A, Shmidt E, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol. 2011;136:128–37.CrossRefPubMedGoogle Scholar
  11. 11.
    Philips AC, Sahney A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4:186–95.Google Scholar
  12. 12.
    Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother. 2000;54:368–72.CrossRefPubMedGoogle Scholar
  13. 13.
    Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut. 2013;62:43–52.CrossRefPubMedGoogle Scholar
  14. 14.
    Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, Eds. Harrison’s Principles of Internal Medicine. 19th ed. New York: Mc Graw Hill;2015:1989–95.Google Scholar
  15. 15.
    Maiwall R, Goel A, Pulimood AB, et al. Investigation into celiac disease in Indian patients with portal hypertension. Indian J Gastroenterol. 2014;33:517–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Lindgren S, Sjoberg K, Eriksson S. Unsuspected celiac disease in chronic cryptogenic liver disease. Scand J Gastroenterol. 1994;29:661–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Stevens FM, McLoughlin RM. Celiac disease is potentially treatable cause of liver failure. Eur J Gastroenterol Hepatol. 2005;17:1015–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122:881–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Korponay-Szabó IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut. 2004;53:641–8.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Davison S. Coeliac disease and liver dysfunction. Arch Dis Child. 2002;87:293–6.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bardella MT, Vecchi M, Conte D, et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology. 1999;29:654–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Bonamico M, Pitzalis G, Culasso F, et al. Hepatic damage during celiac disease in childhood. Minerva Pediatr. 1986;38:959–63.PubMedGoogle Scholar
  23. 23.
    Volta U, De Franceschi L, Lari F, et al. Celiac disease hidden by cryptogenic hypertransaminasemia. Lancet. 1998;352:26–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Ozkan M, Trandafir L, Bozomitu L, et al. Liver involvement in celiac disease in children. Rev Med Chir Soc Med Nat Iasi. 2011;115:1030–4.PubMedGoogle Scholar
  25. 25.
    Singh P, Agnihotri A, Jindal G, et al. Celiac disease and chronic liver disease: is there a relationship? Indian J Gastroenterol. 2013;32:404–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Das P, Makharia GK. Gut-liver axis and disease infidelity: a subject worth exploring. Indian J Gastroenterol. 2014;33:503–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Yasutake K, Kohjima M, Nakashima M, Kotoh K, Nakamuta M, Enjoji M. Nutrition therapy for liver diseases based on the status of nutritional intake. Gastroenterol Res Pract. 2012;2012:85WE9697.CrossRefGoogle Scholar

Copyright information

© Indian Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of GastroenterologySardar Patel Medical CollegeBikanerIndia
  2. 2.Department of General MedicineSardar Patel Medical CollegeBikanerIndia
  3. 3.Department of PediatricsSardar Patel Medical CollegeBikanerIndia

Personalised recommendations